Table 2.

Clinical characteristics of study patients (n = 79).

		Non-MALT (n = 63)	MALT (n = 16)
Age (years, median (range))		53 (43–63)	56 (32–80)
Gender (n (%))	Male	28 (45%)	9 (56%)
	Female	34 (55%)	7 (44%)
Stage (n (%))	I/II, IIE	44 (71%)	13 (81%)
	IV	19 (29%)	3 (19%)
Karnofsky performance status (n (%))	≥80	56 (89%)	12 (75%)
	<80	7 (11%)	4 (25%)
LDH level (n (%))	>240 mg	26 (42%)	9 (56%)
	Normal range	28 (45%)	5 (31%)
	Unknown	9 (13%)	2 (13%)

MALT: mucosa associated lymphoid tissue, LDH: lactate dehydrogenase.